SCHEMBL25820590

SCHEMBL25820590

CS(=O)(=O)c1ccc2nccc(Nc3cccc(C(=O)Nc4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 7/20 0.63
DNMT3A Q9Y6K1 6/20 0.63
DNMT3L Q9UJW3 4/20 0.55
EHMT1 Q9H9B1 2/20 0.55
RIPK2 O43353 3/20 0.54
KDR P35968 2/20 0.52
GAK O14976 1/20 0.51
PDE4B Q07343 2/20 0.50
RET P07949 1/20 0.49
MAPK14 Q16539 1/20 0.49
PKMYT1 Q99640 1/20 0.49
MAP4K4 O95819 1/20 0.48
TGFBR1 P36897 1/20 0.48
USP2 O75604 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
EGFR P00533 1/20 0.46
CLK1 P49759 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24009937 0.94 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1RIPK2
SCHEMBL30290892 0.94 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1RIPK2
SCHEMBL24006360 0.91 DNMT1 (0.64) DNMT1DNMT3ADNMT3LEHMT1RIPK2
SCHEMBL25820587 0.90 DNMT1 (0.63) DNMT1DNMT3ADNMT3LEHMT1USP2
SCHEMBL24004050 0.89 DNMT1 (0.61) DNMT1DNMT3ADNMT3LEHMT1RIPK2
SCHEMBL25820561 0.86 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MAPK14
SCHEMBL25819893 0.86 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1USP2
SCHEMBL25820897 0.86 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MAPK14
SCHEMBL25819896 0.85 DNMT1 (0.69) DNMT1DNMT3ADNMT3LEHMT1USP2
SCHEMBL24009936 0.85 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.